Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections.

Interleukin-12 (IL-12), a heterodimeric cytokine (p35/p40) produced mainly from macrophages and dendritic cells, is an important regulator of T-helper 1 cell responses and for host defense. We found that interferon (IFN) consensus sequence binding protein (ICSBP), which is a transcription factor essential for the expression of p40, was expressed in mouse bone marrow-derived mast cells (BMMCs). The transcription levels of p35 and p40 were increased by stimulation of BMMCs with IFN-gamma/lipopolysaccharide (LPS). IL-12 was secreted from BMMCs in response to LPS but not by FcepsilonRI cross-linking. The p40 levels in the peritoneal cavity of mast cell-deficient W/W(v) and W/W(v) reconstituted with p40(-/-) BMMCs were significantly lower than those of WBB6F(1)(+/+) and wild-type (WT) BMMC-reconstituted W/W(v) in the acute septic peritonitis model. The survival rate of W/W(v) reconstituted with p40(-/-) BMMCs was significantly decreased compared to those of WBB6F(1)(+/+) and WT-BMMC-reconstituted W/W(v), which was due to reduced production of IFN-gamma and subsequent impaired activation of neutrophils in the peritoneal cavity. Survival rate of p40(-/-) mice was also restored by adoptive transfer of WT-BMMCs. These results demonstrate that mast cells play a significant role in the production of IL-12 required for host defense. This is the first report to demonstrate that mast cells are a crucial source of functional IL-12.

[1]  F. Liew,et al.  IL-12, but Not IL-18, Is Critical to Neutrophil Activation and Resistance to Polymicrobial Sepsis Induced by Cecal Ligation and Puncture1 , 2006, The Journal of Immunology.

[2]  M. Nishiyama,et al.  FOG-1 represses GATA-1-dependent FcϵRI β-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice , 2006 .

[3]  J. Rivera Adaptors discriminate mast-cell cytokine production from eicosanoid production and degranulation. , 2006, Trends in immunology.

[4]  C. Hunter New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions , 2005, Nature Reviews Immunology.

[5]  R. de Waal Malefyt,et al.  IL‐12 and IL‐23: master regulators of innate and adaptive immunity , 2004, Immunological reviews.

[6]  A. Gottlieb,et al.  A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. , 2004, The Journal of investigative dermatology.

[7]  R. Kastelein,et al.  IL-23 Provides a Limited Mechanism of Resistance to Acute Toxoplasmosis in the Absence of IL-121 , 2004, The Journal of Immunology.

[8]  M. Nishiyama,et al.  Functional analysis of PU.1 domains in monocyte‐specific gene regulation , 2004, FEBS letters.

[9]  C. Hölscher The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases , 2004, Medical Microbiology and Immunology.

[10]  M. Nishiyama,et al.  Overproduction of PU.1 in mast cell progenitors: its effect on monocyte- and mast cell-specific gene expression. , 2004, Biochemical and biophysical research communications.

[11]  S. Plevy,et al.  Activation of the Murine Interleukin-12 p40 Promoter by Functional Interactions between NFAT and ICSBP* , 2003, Journal of Biological Chemistry.

[12]  Y. Okayama,et al.  Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. , 2003, Blood.

[13]  R. Kastelein,et al.  Novel IL-12 family members shed light on the orchestration of Th1 responses , 2003, Trends in Immunology.

[14]  M. Scott,et al.  Natural Killer Cells Participate in Bacterial Clearance During Septic Peritonitis Through Interactions with Macrophages , 2003, Shock.

[15]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[16]  A. Sher,et al.  ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro. , 2003, Blood.

[17]  M. Nishiyama,et al.  Regulation of Cell Type-Specific Mouse FcεRI β-Chain Gene Expression by GATA-1 Via Four GATA Motifs in the Promoter1 , 2003, The Journal of Immunology.

[18]  I. Wang,et al.  IRF‐8/ICSBP and IRF‐1 cooperatively stimulate mouse IL‐12 promoter activity in macrophages , 2002, FEBS letters.

[19]  S. Akira,et al.  Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. , 2002, The Journal of clinical investigation.

[20]  M. Nishiyama,et al.  Regulation of Human FcεRI α-Chain Gene Expression by Multiple Transcription Factors , 2002, The Journal of Immunology.

[21]  M. Arock,et al.  The role of mast cells in host defense and their subversion by bacterial pathogens. , 2002, Trends in immunology.

[22]  B. Echtenacher,et al.  Differences in Innate Defense Mechanisms in Endotoxemia and Polymicrobial Septic Peritonitis , 2001, Infection and Immunity.

[23]  S. Schwartzbach,et al.  Deletional Analysis of the Murine IL-12 p35 Promoter Comparing IFN-γ and Lipopolysaccharide Stimulation1 , 2001, The Journal of Immunology.

[24]  A. Lentsch,et al.  STAT4 Is Required for Antibacterial Defense but Enhances Mortality during Polymicrobial Sepsis , 2001, Clinical Diagnostic Laboratory Immunology.

[25]  E. Farber,et al.  Mast cell density and IL‐8 expression in nonlesional and lesional psoriatic skin , 2001, International journal of dermatology.

[26]  A. Nakao,et al.  Protective Roles of Mast Cells Against Enterobacterial Infection Are Mediated by Toll-Like Receptor 41 , 2001, The Journal of Immunology.

[27]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[28]  P. Scott,et al.  IL-12 Is Required to Maintain a Th1 Response During Leishmania major Infection1 , 2000, The Journal of Immunology.

[29]  A. Sher,et al.  Cutting Edge: IL-12 Is Required for the Maintenance of IFN-γ Production in T Cells Mediating Chronic Resistance to the Intracellular Pathogen, Toxoplasma gondii , 2000, The Journal of Immunology.

[30]  G. Trinchieri,et al.  An IFN-γ-Inducible Transcription Factor, IFN Consensus Sequence Binding Protein (ICSBP), Stimulates IL-12 p40 Expression in Macrophages , 2000, The Journal of Immunology.

[31]  S. Abraham,et al.  Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis , 2000, Journal of leukocyte biology.

[32]  T. Irimura,et al.  Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. , 1999, The Journal of clinical investigation.

[33]  M. Atchison,et al.  Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages. , 1999, Journal of immunology.

[34]  B. Torbett,et al.  Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression. , 1999, Journal of immunology.

[35]  C. Ra,et al.  The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor alpha-chain gene. , 1999, Journal of immunology.

[36]  S. Holgate,et al.  Immunopathology and human mast cell cytokines. , 1999, Critical reviews in oncology/hematology.

[37]  R. Strieter,et al.  Multiple roles for IL-12 in a model of acute septic peritonitis. , 1999, Journal of immunology.

[38]  G. Kollias,et al.  The c-kit Ligand, Stem Cell Factor, Can Enhance Innate Immunity Through Effects on Mast Cells , 1998, The Journal of experimental medicine.

[39]  A. Sher,et al.  Interferon Consensus Sequence Binding Protein–deficient Mice Display Impaired Resistance to Intracellular Infection Due to a Primary Defect in Interleukin 12 p40 Induction , 1997, The Journal of experimental medicine.

[40]  N. Giese,et al.  Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression , 1997, The Journal of experimental medicine.

[41]  I. Orme,et al.  Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.

[42]  G. Ciliberto,et al.  Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.

[43]  G. Trinchieri,et al.  Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). , 1997, Current opinion in immunology.

[44]  J. Waring,et al.  Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene , 1996, Cell.

[45]  K. Croitoru,et al.  Rat peritoneal mast cells produce IFN-gamma following IL-12 treatment but not in response to IgE-mediated activation. , 1996, Journal of immunology.

[46]  J. Lederer,et al.  Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. , 1996, Surgery.

[47]  B. Echtenacher,et al.  Critical protective role of mast cells in a model of acute septic peritonitis , 1996, Nature.

[48]  S. Galli,et al.  The two faces of the mast cell , 1996, Nature.

[49]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[50]  A. Enk,et al.  IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. , 1995, Journal of immunology.

[51]  K. Murphy,et al.  Regulation of interleukin 12 p40 expression through an NF-kappa B half-site , 1995, Molecular and cellular biology.

[52]  P. Puccetti,et al.  IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. , 1994, Journal of immunology.

[53]  J. Weis,et al.  Preferential expression of interleukin‐12 or interleukin‐4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin‐3 , 1994, European journal of immunology.

[54]  G. Trinchieri,et al.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.

[55]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[56]  Giorgio,et al.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.

[57]  P. Familletti,et al.  Cloning and expression of murine IL-12. , 1992, Journal of immunology.

[58]  P. Familletti,et al.  Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Hewick,et al.  Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. , 1991, Journal of immunology.

[60]  B. Echtenacher,et al.  Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. , 1990, Journal of immunology.

[61]  E. Appella,et al.  An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[62]  G. Trinchieri,et al.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.

[63]  S. Galli,et al.  Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell- deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells , 1985, The Journal of experimental medicine.

[64]  K. Austen,et al.  Immunologic Release of β-Hexosaminidase and β-Glucuronidase from Purified Rat Serosal Mast Cells , 1979, Journal of Immunology.

[65]  M. Nishiyama,et al.  FOG-1 represses GATA-1-dependent FcepsilonRI beta-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice. , 2006, Blood.

[66]  伊藤 友章 Mast cells acquire monocyte-specific gene expression and monocyte-like morphology by overproduction of PU.1 , 2005 .

[67]  M. Nishiyama,et al.  Regulation of cell type-specific mouse Fc epsilon RI beta-chain gene expression by GATA-1 via four GATA motifs in the promoter. , 2003, Journal of immunology.

[68]  K. Ozato,et al.  ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[69]  K. Austen,et al.  Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. , 1979, Journal of immunology.